These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 37816983

  • 1. Genetic variants of MTHFR gene in relation to folic acid levels and bone mineral density in Polish patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE, Hryhorowicz S, Szymczak-Tomczak A, Wysocka E, Michalak M, Kaczmarek-Ryś M, Lis-Tanaś E, Bielawska L, Pławski A, Słomski R, Dobrowolska A, Krela-Kaźmierczak I.
    J Appl Genet; 2024 Feb; 65(1):73-81. PubMed ID: 37816983
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
    Szymczak-Tomczak A, Krela-Kaźmierczak I, Kaczmarek-Ryś M, Hryhorowicz S, Stawczyk-Eder K, Szalata M, Skrzypczak-Zielińska M, Łykowska-Szuber L, Eder P, Michalak M, Dobrowolska A, Słomski R.
    Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
    [Abstract] [Full Text] [Related]

  • 3. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I, Michalak M, Wawrzyniak A, Szymczak A, Eder P, Łykowska-Szuber L, Kaczmarek-Ryś M, Drwęska-Matelska N, Skrzypczak-Zielińska M, Linke K, Słomski R.
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [Abstract] [Full Text] [Related]

  • 4. Impact of Folate Intake on Bone Mineral Density in Patients with Inflammatory Bowel Disease.
    Ratajczak-Pawłowska AE, Szymczak-Tomczak A, Michalak M, Rychter AM, Zawada A, Skoracka K, Dobrowolska A, Krela-Kaźmierczak I.
    Nutrients; 2023 Dec 19; 16(1):. PubMed ID: 38201836
    [Abstract] [Full Text] [Related]

  • 5. Physical activity, quality of diet and bone mineral density in patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE, Michalak M, Szymczak-Tomczak A, Rychter AM, Zawada A, Skoracka K, Dobrowolska A, Krela-Kaźmierczak I.
    J Hum Nutr Diet; 2023 Oct 19; 36(5):1692-1700. PubMed ID: 37403249
    [Abstract] [Full Text] [Related]

  • 6. Risk Factors of Low Bone Mineral Density in Newly Diagnosed Pediatric Inflammatory Bowel Disease.
    Ahn MB, Yoo IH.
    Nutrients; 2023 Dec 08; 15(24):. PubMed ID: 38140307
    [Abstract] [Full Text] [Related]

  • 7. Bone density and bone metabolism in patients with inflammatory bowel disease.
    Shirazi KM, Somi MH, Rezaeifar P, Fattahi I, Khoshbaten M, Ahmadzadeh M.
    Saudi J Gastroenterol; 2012 Dec 08; 18(4):241-7. PubMed ID: 22824766
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D, Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and FokI), and Bone Mineral Density in Patients With Inflammatory Bowel Disease.
    Szymczak-Tomczak A, Kaczmarek-Ryś M, Hryhorowicz S, Michalak M, Eder P, Skrzypczak-Zielińska M, Łykowska-Szuber L, Tomczak M, Słomski R, Dobrowolska A, Krela-Kaźmierczak I.
    J Clin Densitom; 2021 Dec 08; 24(2):233-242. PubMed ID: 33172802
    [Abstract] [Full Text] [Related]

  • 9. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
    Ewid M, Al Mutiri N, Al Omar K, Shamsan AN, Rathore AA, Saquib N, Salaas A, Al Sarraj O, Nasri Y, Attal A, Tawfiq A, Sherif H.
    World J Gastroenterol; 2020 Sep 21; 26(35):5343-5353. PubMed ID: 32994692
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
    Krela-Kaźmierczak I, Michalak M, Szymczak-Tomczak A, Łykowska-Szuber L, Stawczyk-Eder K, Waszak K, Kucharski MA, Dobrowolska A, Eder P.
    Pol Arch Intern Med; 2018 Aug 31; 128(7-8):447-454. PubMed ID: 30057387
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density and the 570A>T polymorphism of the bone morphogenetic protein 2 (BMP2) gene in patients with inflammatory bowel disease: a cross-sectional study.
    Krela-Kazmierczak I, Wawrzyniak A, Szymczak A, Eder P, Lykowska-Szuber L, Michalak M, Drweska-Matelska N, Kaczmarek-Rys M, Skrzypczak-Zielinska M, Szalata M, Slomski R.
    J Physiol Pharmacol; 2017 Oct 31; 68(5):757-764. PubMed ID: 29375051
    [Abstract] [Full Text] [Related]

  • 12. The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization.
    Xu D, Chen Y, Gao X, Xie W, Wang Y, Shen J, Yang G, Xie B.
    Front Immunol; 2023 Oct 31; 14():1148107. PubMed ID: 37275908
    [Abstract] [Full Text] [Related]

  • 13. Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.
    te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, van Beek RD, van der Sluis IM, Hop WC, Pieters R, van den Heuvel-Eibrink MM.
    Bone; 2011 Mar 01; 48(3):571-7. PubMed ID: 20955826
    [Abstract] [Full Text] [Related]

  • 14. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
    Even Dar R, Mazor Y, Karban A, Ish-Shalom S, Segal E.
    Dig Dis; 2019 Mar 01; 37(4):284-290. PubMed ID: 30799399
    [Abstract] [Full Text] [Related]

  • 15. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M, Landowski P, Kamińska B, Góra-Gebka M, Popadiuk S, Renke J.
    Med Wieku Rozwoj; 2006 Mar 01; 10(2):445-51. PubMed ID: 16825715
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
    Jahnsen J, Falch JA, Mowinckel P, Aadland E.
    Scand J Gastroenterol; 2004 Feb 01; 39(2):145-53. PubMed ID: 15000276
    [Abstract] [Full Text] [Related]

  • 17. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
    Senhaji N, Serbati N, Diakité B, Arazzakou S, Hamzi K, Badre W, Nadifi S.
    Gene; 2013 May 25; 521(1):45-9. PubMed ID: 23542077
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.
    Int J Colorectal Dis; 2006 Dec 25; 21(8):758-66. PubMed ID: 16463035
    [Abstract] [Full Text] [Related]

  • 19. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
    Bastos CM, Araújo IM, Nogueira-Barbosa MH, Salmon CEG, de Paula FJA, Troncon LEA.
    Osteoporos Int; 2017 Jul 25; 28(7):2167-2176. PubMed ID: 28405731
    [Abstract] [Full Text] [Related]

  • 20. Association between the methylenetetrahydrofolate reductase c.677C>T polymorphism and bone mineral density: an updated meta-analysis.
    Li HZ, Wang W, Liu YL, He XF.
    Mol Genet Genomics; 2016 Feb 25; 291(1):169-80. PubMed ID: 26231982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.